Glucophage

Glucophage is a prescription oral medication containing the active ingredient metformin hydrochloride, presented in tablet form (strength and dosage form may vary) and marketed in the European Union. It belongs to the biguanide class of antidiabetic agents and works by decreasing hepatic glucose production, reducing intestinal glucose absorption, and enhancing peripheral insulin sensitivity. Glucophage is commonly used to manage blood glucose levels in adults effectively.

Glucophage is indicated for several metabolic conditions where control of blood glucose is required.

- Type 2 diabetes mellitus as part of diet and exercise therapy. - Management of hyperglycemia in patients with type 2 diabetes who are overweight or obese. - Adjunct therapy for polycystic ovary syndrome (PCOS) to improve insulin resistance. - Off‑label use under medical supervision for gestational diabetes prevention in high‑risk women. - Combination therapy with other oral antidiabetics when monotherapy does not achieve glycemic targets. - Use in renal‑impairment adjusted dosing under physician guidance.

Glucophage may cause a range of adverse effects, most of which are mild and transient, while rare events can be serious.

Common: - Nausea or upset stomach. - Diarrhea. - Abdominal discomfort or flatulence. - Metallic taste. - Decreased appetite.

Serious: - Lactic acidosis (rare but life‑threatening). - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity.

Before starting Glucophage, clinicians should evaluate several safety considerations to minimize risk.

- Assess renal function; avoid use if eGFR is below the recommended threshold. - Review hepatic status; exercise caution in patients with liver disease. - Monitor for signs of lactic acidosis, especially after surgery or acute illness. - Use with caution in elderly patients due to higher risk of vitamin B12 deficiency. - Avoid excessive alcohol consumption, which can increase lactic acidosis risk. - Evaluate pregnancy and breastfeeding status; benefits must outweigh potential risks.

Glucophage can interact with other medicines, affecting its efficacy or safety.

Avoid: - Concomitant use with iodinated contrast agents (risk of renal impairment). - Co‑administration with potent CYP450 inhibitors such as cimetidine that may increase metformin levels.

Use with caution: - Combined therapy with other antidiabetic agents (risk of hypoglycemia). - NSAIDs or diuretics that may affect renal function. - Alcohol consumption (increases lactic acidosis risk).